Cargando…

The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population

BACKGROUND: Despite growing evidence that N-terminal pro-brain natriuretic peptide (NT-proBNP) has an important prognostic value for patients with cardiovascular disease, chronic kidney disease, etc, the prognostic significance of NT-proBNP levels in the general population has not been established....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Qiwei, Xiao, Wenkai, Bai, Yongyi, Ye, Ping, Luo, Leiming, Gao, Peng, Wu, Hongmei, Bai, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777226/
https://www.ncbi.nlm.nih.gov/pubmed/27013868
http://dx.doi.org/10.2147/CIA.S98151
_version_ 1782419263648169984
author Zhu, Qiwei
Xiao, Wenkai
Bai, Yongyi
Ye, Ping
Luo, Leiming
Gao, Peng
Wu, Hongmei
Bai, Jie
author_facet Zhu, Qiwei
Xiao, Wenkai
Bai, Yongyi
Ye, Ping
Luo, Leiming
Gao, Peng
Wu, Hongmei
Bai, Jie
author_sort Zhu, Qiwei
collection PubMed
description BACKGROUND: Despite growing evidence that N-terminal pro-brain natriuretic peptide (NT-proBNP) has an important prognostic value for patients with cardiovascular disease, chronic kidney disease, etc, the prognostic significance of NT-proBNP levels in the general population has not been established. The aim of this study was to evaluate the clinical significance of NT-proBNP in a community population. METHODS: This is a community-based prospective survey of residents from two communities in Beijing conducted for a routine health status checkup. Out of 1,860 individuals who were eligible for inclusion from 2007 to 2009, 1,499 completed a follow-up and were assessed for the prognostic value of NT-proBNP in 2013. A questionnaire was used for end point events. Anthropometry and blood pressure were measured. Plasma NT-proBNP, creatinine, lipids, and glucose were determined. RESULTS: A total of 1,499 subjects with complete data were included in the analysis. Participants were divided into four groups according to baseline NT-proBNP levels (quartile 1, <19.8 pg/mL; quartile 2, 19.8–41.6 pg/mL; quartile 3, 41.7–81.8 pg/mL; quartile 4, ≥81.9 pg/mL). During a median 4.8-year follow-up period, the all-cause mortality rate rose from 0.8% in the lowest concentration NT-proBNP group (<19.8 pg/mL) to 7.8% in the highest NT-proBNP group (≥81.9 pg/mL; P<0.001). The incidence of major adverse cardiovascular events (MACEs) increased from 3.1% in the lowest NT-proBNP group to 18.9% in the highest group (P<0.001). Individuals in the highest NT-proBNP group (≥81.9 pg/mL) were associated with higher risk of all-cause death and MACEs compared with the lowest NT-proBNP group using Kaplan–Meier survival curves and the Cox proportional hazard model after adjusting for age, sex, and traditional risk factors. CONCLUSION: The plasma NT-proBNP level is a strong and independent prognosis factor for all-cause death and MACEs in the community population. The NT-proBNP cut-point for the prognostic value remains to be further studied. NT-proBNP is a strong and independent prognostic factor for all-cause death and MACEs in individuals older than 65 years and MACEs in individuals younger than 65 years.
format Online
Article
Text
id pubmed-4777226
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-47772262016-03-24 The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population Zhu, Qiwei Xiao, Wenkai Bai, Yongyi Ye, Ping Luo, Leiming Gao, Peng Wu, Hongmei Bai, Jie Clin Interv Aging Original Research BACKGROUND: Despite growing evidence that N-terminal pro-brain natriuretic peptide (NT-proBNP) has an important prognostic value for patients with cardiovascular disease, chronic kidney disease, etc, the prognostic significance of NT-proBNP levels in the general population has not been established. The aim of this study was to evaluate the clinical significance of NT-proBNP in a community population. METHODS: This is a community-based prospective survey of residents from two communities in Beijing conducted for a routine health status checkup. Out of 1,860 individuals who were eligible for inclusion from 2007 to 2009, 1,499 completed a follow-up and were assessed for the prognostic value of NT-proBNP in 2013. A questionnaire was used for end point events. Anthropometry and blood pressure were measured. Plasma NT-proBNP, creatinine, lipids, and glucose were determined. RESULTS: A total of 1,499 subjects with complete data were included in the analysis. Participants were divided into four groups according to baseline NT-proBNP levels (quartile 1, <19.8 pg/mL; quartile 2, 19.8–41.6 pg/mL; quartile 3, 41.7–81.8 pg/mL; quartile 4, ≥81.9 pg/mL). During a median 4.8-year follow-up period, the all-cause mortality rate rose from 0.8% in the lowest concentration NT-proBNP group (<19.8 pg/mL) to 7.8% in the highest NT-proBNP group (≥81.9 pg/mL; P<0.001). The incidence of major adverse cardiovascular events (MACEs) increased from 3.1% in the lowest NT-proBNP group to 18.9% in the highest group (P<0.001). Individuals in the highest NT-proBNP group (≥81.9 pg/mL) were associated with higher risk of all-cause death and MACEs compared with the lowest NT-proBNP group using Kaplan–Meier survival curves and the Cox proportional hazard model after adjusting for age, sex, and traditional risk factors. CONCLUSION: The plasma NT-proBNP level is a strong and independent prognosis factor for all-cause death and MACEs in the community population. The NT-proBNP cut-point for the prognostic value remains to be further studied. NT-proBNP is a strong and independent prognostic factor for all-cause death and MACEs in individuals older than 65 years and MACEs in individuals younger than 65 years. Dove Medical Press 2016-02-16 /pmc/articles/PMC4777226/ /pubmed/27013868 http://dx.doi.org/10.2147/CIA.S98151 Text en © 2016 Zhu et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Zhu, Qiwei
Xiao, Wenkai
Bai, Yongyi
Ye, Ping
Luo, Leiming
Gao, Peng
Wu, Hongmei
Bai, Jie
The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population
title The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population
title_full The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population
title_fullStr The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population
title_full_unstemmed The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population
title_short The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population
title_sort prognostic value of the plasma n-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777226/
https://www.ncbi.nlm.nih.gov/pubmed/27013868
http://dx.doi.org/10.2147/CIA.S98151
work_keys_str_mv AT zhuqiwei theprognosticvalueoftheplasmanterminalprobrainnatriureticpeptidelevelonallcausedeathandmajorcardiovasculareventsinacommunitybasedpopulation
AT xiaowenkai theprognosticvalueoftheplasmanterminalprobrainnatriureticpeptidelevelonallcausedeathandmajorcardiovasculareventsinacommunitybasedpopulation
AT baiyongyi theprognosticvalueoftheplasmanterminalprobrainnatriureticpeptidelevelonallcausedeathandmajorcardiovasculareventsinacommunitybasedpopulation
AT yeping theprognosticvalueoftheplasmanterminalprobrainnatriureticpeptidelevelonallcausedeathandmajorcardiovasculareventsinacommunitybasedpopulation
AT luoleiming theprognosticvalueoftheplasmanterminalprobrainnatriureticpeptidelevelonallcausedeathandmajorcardiovasculareventsinacommunitybasedpopulation
AT gaopeng theprognosticvalueoftheplasmanterminalprobrainnatriureticpeptidelevelonallcausedeathandmajorcardiovasculareventsinacommunitybasedpopulation
AT wuhongmei theprognosticvalueoftheplasmanterminalprobrainnatriureticpeptidelevelonallcausedeathandmajorcardiovasculareventsinacommunitybasedpopulation
AT baijie theprognosticvalueoftheplasmanterminalprobrainnatriureticpeptidelevelonallcausedeathandmajorcardiovasculareventsinacommunitybasedpopulation
AT zhuqiwei prognosticvalueoftheplasmanterminalprobrainnatriureticpeptidelevelonallcausedeathandmajorcardiovasculareventsinacommunitybasedpopulation
AT xiaowenkai prognosticvalueoftheplasmanterminalprobrainnatriureticpeptidelevelonallcausedeathandmajorcardiovasculareventsinacommunitybasedpopulation
AT baiyongyi prognosticvalueoftheplasmanterminalprobrainnatriureticpeptidelevelonallcausedeathandmajorcardiovasculareventsinacommunitybasedpopulation
AT yeping prognosticvalueoftheplasmanterminalprobrainnatriureticpeptidelevelonallcausedeathandmajorcardiovasculareventsinacommunitybasedpopulation
AT luoleiming prognosticvalueoftheplasmanterminalprobrainnatriureticpeptidelevelonallcausedeathandmajorcardiovasculareventsinacommunitybasedpopulation
AT gaopeng prognosticvalueoftheplasmanterminalprobrainnatriureticpeptidelevelonallcausedeathandmajorcardiovasculareventsinacommunitybasedpopulation
AT wuhongmei prognosticvalueoftheplasmanterminalprobrainnatriureticpeptidelevelonallcausedeathandmajorcardiovasculareventsinacommunitybasedpopulation
AT baijie prognosticvalueoftheplasmanterminalprobrainnatriureticpeptidelevelonallcausedeathandmajorcardiovasculareventsinacommunitybasedpopulation